亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

隨州市紅旗化工有限公司  

醫藥原料醫藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 妥布霉素,妥布霉素堿CAS No.:32986-56-4
妥布霉素,妥布霉素堿CAS No.:32986-56-4
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 32986-56-4
過期 長期有效
更新 2020-06-18 10:08
 
詳細信息

中文名:妥布霉素,妥布霉素堿
CAS No.:32986-56-4
化學名:O-3-氨基-3-脫氧-alpha-O-葡吡喃糖基-(1-6)-O-[2,6-二氨基-2,3,6-三脫氧-alpha-D-核-己吡喃糖基-(1→4)]-2-脫氧-D-鏈霉胺
英文名:Tobramycin Base

分子式:C18H37N5O9
分子量:467.51
 
質量標準:USP31.
含量:99%
性狀描述:白色或類白色吸濕性粉末
作用:妥布霉素能夠聯結在30S和50S的聯結位置,阻礙70S復合物的形成,使mRNA不能翻譯成蛋白質,導致細胞死亡。臨床主要用于敏感細菌引起的嚴重感染,如革蘭陰性菌特別是綠膿桿菌、大腸桿菌及肺炎桿菌等引起的燒傷感染、敗血癥、呼吸系統感染、泌尿系統感染、膽囊膽道感染及軟組織嚴重感染等。
包裝:25KG/紙板桶
 

©2025 隨州市紅旗化工有限公司 版權所有   技術支持:化工網   訪問量:31570  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |